[Use of semisynthetic human insulin in juvenile insulin-dependent diabetes mellitus]

Area of Science:

• Pediatric Endocrinology
• Metabolic Disorders
• Pharmacology

Background:

• Insulin-dependent diabetes mellitus (IDDM) requires lifelong management.
• Different insulin formulations are available for pediatric patients.
• Comparing the efficacy of various insulin types is crucial for optimal patient care.

Purpose of the Study:

• To compare the clinical and metabolic effects of semisynthetic human insulin versus monocomponent porcine insulin in pediatric IDDM patients.
• To evaluate treatment outcomes over a two-year follow-up period.

Main Methods:

• A two-year prospective study involving 28 pediatric patients diagnosed with IDDM.
• Patients were randomized into two groups: 14 treated with semisynthetic human insulin and 14 with monocomponent porcine insulin.
• Regular monitoring of clinical and metabolic parameters was performed.

Main Results:

• No statistically significant differences were observed between the two treatment groups.
• Key clinical parameters (e.g., growth, glycemic control) showed comparable results.
• Metabolic parameters (e.g., HbA1c, lipid profiles) were similar in both insulin groups.

Conclusions:

• Semisynthetic human insulin and monocomponent porcine insulin appear to be equally effective in managing pediatric IDDM.
• The choice of insulin may not significantly impact short-term clinical and metabolic outcomes in this population.
• Further long-term studies may be warranted to explore potential subtle differences.